Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 80,330 shares at $16.30 ($1.3M) on 2023-07-03, disclosed to the SEC on 2023-07-03.
Scheduled sale ($1.3M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.49 | 17,281 | $285K | 21.2% |
| 2 | $16.49 | 17,281 | $285K | 21.2% |
| 3 | $16.97 | 18,819 | $319K | 23.8% |
| 4 | $16.97 | 18,819 | $319K | 23.8% |
| 5 | $16.30 | 3,865 | $63K | 4.7% |
| 6 | $16.30 | 3,865 |
| $63K |
| 4.7% |
| 7 | $17.04 | 400 | $7K | 0.5% |
| Total | $16.70 avg | 80,330 | $1.3M | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |